Executive Director, Asset Team Lead
Recursion · Remote Opportunity - United States
CHECKED 37M AGO
Bio & Science AIremoteexecutive
At a glance
Highlights
- Drive asset strategy for small-molecule oncology and immunology programs.
- Translate Recursion OS and ClinTech insights into portfolio advantages.
- Shape competitive narratives that guide leadership and partnering decisions.
Ideal candidate
A strategic scientific leader with deep oncology and inflammation drug development experience who thrives translating complexity into conviction-led decisions and is driven to deliver transformative medicines to patients.
Requirements
- PhD in life sciences or related scientific discipline with deep drug discovery and development expertise
- 10+ years of biotech/pharma experience with asset-level strategic leadership advancing programs through clinical stage-gates
- Deep expertise in small molecule therapeutics development for oncology and immunology/inflammation
- Experience leveraging computational approaches and data-driven platforms to sharpen asset strategy and clinical decision-making
- Proven ability to build strategic and competitive case for clinical assets integrating differentiation, regulatory and market dynamics
- Strong financial acumen on resourcing, asset valuation and portfolio trade-offs with exceptional executive presence
- hiring process
- Applications reviewed with Greenhouse Talent Matching AI support; final decisions by human recruiters and hiring managers, with accommodations available on request.
Lab profile
About Recursion
AI-native biotech industrializing drug discovery with automation and data to advance oncology and rare disease medicines.
What they build
- Recursion OS drug discovery platform
- Oncology clinical pipeline
- Rare disease clinical pipeline
Known for
- AI-native end-to-end drug discovery
- Computational biology for early discovery
- Clinical development in oncology and rare disease
Key facts
- Founded 2013
- Headquartered in Salt Lake City, Utah
- Public company (Nasdaq: RXRX)